cjc-1295 & ipamorelin: Tesamorelin (Mod GRF 1-29) & Ipamorelin (12mg) CJC-1295 w/o DAC + IPA

doi: 10.1016/j.reprotox.2024.108682

Unlike current PD treatments that primarily alleviate symptoms, bilirubin's multi-target nature may allow simultaneous intervention in multiple disease progression pathways, achieving multi-efficacy with a single agent. However, translating bilirubin into clinical therapy still faces challenges: determining the optimal treatment window, selecting administration routes (especially efficient blood-brain barrier penetration), evaluating long-term safety, and establishing individualized dosing regimens all require in-depth research

Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer

-Hydroxybutyrate and medium-chain fatty acids are metabolized by different cell types in mouse cerebral cortex slices

Reliable and Reproducible Results: Rigorous quality control ensures high data accuracy and consistency